Policlinico San Donato S.p.A.

Heart Failure Management

Clinical research at Policlinico San Donato S.p.A. is centered on heart failure, with attention to treatment optimization and long-term disease control in women.

  • Guideline-directed medical therapy
  • Pharmacological optimization
  • Morbidity and mortality
  • Quality of life

The research activity reflects a focused interest in improving management strategies for patients with chronic cardiac dysfunction.

Sex-specific Cardiovascular Care

The sponsor shows a clear therapeutic interest in addressing sex differences in cardiovascular treatment, particularly the underrepresentation of women in optimization pathways for heart failure.

  • Women’s cardiovascular health
  • Sex-gap in treatment
  • Treatment adherence
  • Side-effect burden

Research efforts are directed toward understanding how treatment intensity and tolerability may differ in female patients with advanced cardiac disease.

Therapeutic Titration in Cardiology

The clinical program includes interest in structured up-titration of cardiac medications, with emphasis on how treatment adjustment influences patient outcomes in routine care settings.

  • Medication up-titration
  • Pragmatic multicentre care
  • Drug adherence
  • Treatment tolerability

This area of work is aligned with practical cardiovascular management and the refinement of chronic heart failure therapy.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • A Study Testing Drug Combination for Heart Failure in Women Comparing Increased Doses to Standard Care

    Recruiting

    1 1 1 1
    Italy